Arteris (NASDAQ:AIP) COO Laurent Moll Sells 12,219 Shares of Stock

Arteris, Inc. (NASDAQ:AIP) COO Laurent Moll sold 12,219 shares of the business’s stock in a transaction that occurred on Monday, October 5th. The shares were sold at an average price of $24.29, for a total value of $296,799.51. Following the completion of the transaction, the chief operating officer directly owned 194,659 shares in the company, valued at approximately $4,728,267.11. This trade represents a 5.91% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Arteris Trading Up 0.7%

Shares of AIP stock traded up $0.16 during trading hours on Tuesday, hitting $24.13. 476,272 shares of the company were exchanged, compared to its average volume of 728,847. The firm has a market cap of $1.19 billion, a P/E ratio of -27.74 and a beta of 1.90. Arteris, Inc. has a fifty-two week low of $12.06 and a fifty-two week high of $50.26. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.57 and a current ratio of 1.57. The company has a 50 day simple moving average of $24.73 and a two-hundred day simple moving average of $28.61.

Arteris (NASDAQ:AIP) last released its earnings results on Thursday, August 6th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.06). The company had revenue of $24.13 million for the quarter, compared to analyst estimates of $23.48 million. Arteris had a negative net margin of 46.70% and a negative return on equity of 295.96%. Equities analysts anticipate that Arteris, Inc. will post -0.68 EPS for the current year.

Analyst Upgrades and Downgrades

Several analysts have recently commented on AIP shares. Jefferies Financial Group upgraded Arteris from a “hold” rating to a “buy” rating and raised their target price for the company from $35.00 to $50.00 in a research note on Friday, August 7th. Weiss Ratings raised Arteris from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, August 21st. Rosenblatt Securities restated a “buy” rating and set a $38.00 price objective on shares of Arteris in a report on Friday, August 7th. Roth Capital initiated coverage on Arteris in a research report on Tuesday, August 4th. They set a “buy” rating and a $40.00 target price on the stock. Finally, Craig Hallum started coverage on Arteris in a report on Monday, September 21st. They issued a “buy” rating and a $30.00 target price on the stock. Six research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat, Arteris currently has an average rating of “Moderate Buy” and an average price target of $39.43.

Key Arteris News

Here are the key news stories impacting Arteris this week:

• Positive Sentiment: Arteris won an additional $3.3 million through the Trusted and Assured Microelectronics program to expand its third-party semiconductor IP security-assurance efforts. The company is collaborating with BAE Systems and SiFive, potentially strengthening its position in defense-related and trusted-chip supply chains. Arteris funding announcement
• Neutral Sentiment: CEO K. Charles Janac and Vice President Paul Alpern sold shares, but the filings state the transactions were made to cover tax withholding obligations related to vested equity awards. Because these were tax-related sales rather than clearly discretionary trades, they provide a limited signal about management’s outlook. SEC filing for executive share sales
• Negative Sentiment: Major shareholder Bayview Legacy LLC sold 100,000 shares for approximately $2.38 million, reducing its ownership by 1.22%. The filing did not cite tax withholding as the reason, so the sale could create modest supply pressure and raise concerns about near-term shareholder confidence. SEC filing for Bayview Legacy share sale

Institutional Trading of Arteris

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in AIP. Needham Investment Management LLC boosted its position in shares of Arteris by 2.6% during the fourth quarter. Needham Investment Management LLC now owns 3,411,500 shares of the company’s stock valued at $52,878,000 after buying an additional 86,500 shares during the last quarter. BlackRock Inc. bought a new position in Arteris during the 2nd quarter valued at $160,129,000. Granahan Investment Management LLC boosted its holdings in Arteris by 201.0% during the 1st quarter. Granahan Investment Management LLC now owns 713,077 shares of the company’s stock worth $11,723,000 after acquiring an additional 476,181 shares during the last quarter. Wellington Management Group LLP grew its stake in shares of Arteris by 0.4% in the 2nd quarter. Wellington Management Group LLP now owns 500,200 shares of the company’s stock worth $24,305,000 after acquiring an additional 1,897 shares in the last quarter. Finally, Algert Global LLC bought a new stake in shares of Arteris in the 2nd quarter worth $11,602,000. 64.36% of the stock is owned by institutional investors.

Arteris Company Profile

Arteris, Inc is a semiconductor intellectual property (IP) company that develops technologies used in the design of system-on-chip (SoC) devices. Its products help semiconductor and electronics companies connect, manage and protect the various processing, memory and other functional components integrated into complex chips.

The company’s portfolio includes network-on-chip (NoC) interconnect IP, which supports communication among different elements within an SoC, as well as cache-coherent interconnect, system IP and related design technologies.